![](/img/cover-not-exists.png)
A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy
Qiming Sun, Qian Xu, Xiangbai Dong, Lin Cao, Xiaofeng Huang, Qingang Hu, Zi-Chun HuaVolume:
123
Year:
2008
Language:
english
Pages:
9
DOI:
10.1002/ijc.23537
File:
PDF, 693 KB
english, 2008